These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37746989)

  • 1. Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: A real-world pilot study.
    Abe I; Takeshita K; Nagata M; Fujita Y; Ochi K; Koga M; Kudo T; Shimada H; Abe M; Mukoubara S; Kobayashi K
    Medicine (Baltimore); 2023 Sep; 102(38):e34730. PubMed ID: 37746989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
    Takahashi Y; Biller BMK; Fukuoka H; Ho KKY; Rasmussen MH; Nedjatian N; Sværke C; Yuen KCJ; Johannsson G
    Pituitary; 2023 Feb; 26(1):57-72. PubMed ID: 36380045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
    Johannsson G; Gordon MB; Højby Rasmussen M; Håkonsson IH; Karges W; Sværke C; Tahara S; Takano K; Biller BMK
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1358-76. PubMed ID: 32022863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial.
    Mori J; Ohata Y; Fujisawa Y; Sato Y; Röhrich S; Rasmussen MH; Bang RB; Horikawa R
    Clin Endocrinol (Oxf); 2024 Apr; 100(4):389-398. PubMed ID: 38368603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3.
    Sävendahl L; Battelino T; Højby Rasmussen M; Brod M; Saenger P; Horikawa R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1357-1367. PubMed ID: 34964458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once-weekly somapacitan or daily growth hormone.
    Otsuka F; Takahashi Y; Tahara S; Ogawa Y; Højby Rasmussen M; Takano K
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):620-628. PubMed ID: 32603494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
    Sävendahl L; Battelino T; Brod M; Højby Rasmussen M; Horikawa R; Juul RV; Saenger P;
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1847-61. PubMed ID: 31917835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3.
    Sävendahl L; Battelino T; Højby Rasmussen M; Brod M; Röhrich S; Saenger P; Horikawa R
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2569-2578. PubMed ID: 36995872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.
    Kildemoes RJ; Hollensen C; Biller BMK; Johannsson G; Takahashi Y; Rasmussen MH
    Eur J Endocrinol; 2022 May; 187(1):27-38. PubMed ID: 35521713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation.
    Bidlingmaier M; Biller BMK; Clemmons D; Jørgensen JOL; Nishioka H; Takahashi Y
    Front Endocrinol (Lausanne); 2022; 13():1040046. PubMed ID: 36619571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somapacitan: a long-acting growth hormone derivative for treatment of growth hormone deficiency.
    Paton DM
    Drugs Today (Barc); 2022 Oct; 58(10):509-517. PubMed ID: 36305544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial.
    Miller BS; Blair JC; Rasmussen MH; Maniatis A; Kildemoes RJ; Mori J; Polak M; Bang RB; Böttcher V; Stagi S; Horikawa R
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3378-3388. PubMed ID: 36062966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial.
    Johannsson G; Feldt-Rasmussen U; Håkonsson IH; Biering H; Rodien P; Tahara S; Toogood A; Rasmussen MH;
    Eur J Endocrinol; 2018 May; 178(5):491-499. PubMed ID: 29500310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum afamin and its implications in adult growth hormone deficiency: a prospective GH-withdrawal study.
    Ratku B; Lőrincz H; Csiha S; Sebestyén V; Berta E; Bodor M; Nagy EV; Szabó Z; Harangi M; Somodi S
    Front Endocrinol (Lausanne); 2024; 15():1348046. PubMed ID: 38379862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of growth hormone replacement on energy expenditure and body composition in patients with adult growth hormone deficiency.
    Momozono A; Hayashi A; Takano K; Shichiri M
    Endocr J; 2021 Apr; 68(4):469-475. PubMed ID: 33361693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EXPERT OPINION REVIEW Utilizing somapacitan, a long-acting growth hormone formulation, for the treatment of adult growth hormone deficiency: a guide for the clinician.
    Yuen KCJ
    Endocr Pract; 2024 Jul; ():. PubMed ID: 38992799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of insulin resistance and nocturnal fall of blood pressure in GH-deficient adults during GH replacement.
    Brasil RR; Soares DV; Spina LD; Lobo PM; da Silva EM; Mansur VA; Pinheiro MF; Conceição FL; Vaisman M
    J Endocrinol Invest; 2007 Apr; 30(4):306-12. PubMed ID: 17556867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis.
    Zhou H; Sun L; Zhang S; Wang Y; Wang G
    Pituitary; 2021 Feb; 24(1):130-142. PubMed ID: 32888174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.